Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OC-DC vaccine |
Synonyms | |
Therapy Description |
OC-DC vaccine is a vaccine comprised of autologous dendritic cells (DC) loaded in vitro with lysate from the patient's tumor cells that have been oxidized with hypochlorous acid (PMID: 23838316). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OC-DC vaccine | OC-DC vaccine is a vaccine comprised of autologous dendritic cells (DC) loaded in vitro with lysate from the patient's tumor cells that have been oxidized with hypochlorous acid (PMID: 23838316). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01312376 | Phase I | Fludarabine Cyclophosphamide Bevacizumab CD3/CD28 stimulated/primed autologous Ts OC-DC vaccine | Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer | Terminated | USA | 0 |